SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma gets nod to transfer of API Non-Antibiotic Division to Auro Pharma India

10 Feb 2023 Evaluate

Aurobindo Pharma has received an approval for transfer of units constituting API Non-Antibiotic Division of the company to Auro Pharma India, a wholly owned subsidiary of the company by way of slump sale through a Business Transfer Agreement(s). The completion of the sale is estimated in the first/ second quarter of FY 2023-24. The slump sale(s) shall be effective from April 1, 2023 onwards.

Transfer of API Non-Antibiotic Division will be done for a lumpsum consideration of Rs 3,303.17 crore. This consideration is based on the financial statements of the API Non-Antibiotic Division as on December 31, 2022 (on a cash free basis). The Board of Directors of the Company at its meeting held on February 9, 2023 has approved the same.  

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1385.65 -0.45 (-0.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×